What Comes After DESTINY-Breast09? If T-DXd moves to the first line, what comes next? This discussion explores sequencing strategies, the impact of prior ADC exposure on subsequent responses, and how clinicians think about second-line options after progression. FacebookXRedditPinterestEmail You may also like Video DESTINY-Breast09 & the Future of Care – Dr. Irene Kang & Dr. Aditya Bardia 1 min read Video Why First-Line Therapy Matters in HER2+ Metastatic Breast Cancer 1 min read Video DESTINY-Breast09: Nearly 4 Years of PFS with T-DXd 1 min read Video Who Should Receive T-DXd First Line? 1 min read Video Managing Risk vs Benefit with T-DXd 1 min read Video Dose Optimization: The Secret to Long-Term T-DXd Success 1 min read Recommended Videos Is HER2+ Metastatic Breast Cancer Curable? What Comes Next – Dr. Gregory Vidal & Dr. Nusayba Bagegni 4 months ago Rethinking First-Line Metastatic HER2+ Therapy with T-DXd – Drs. Mouabbi, O’Shaughnessy & Rimawi 4 months ago DESTINY-Breast11, DESTINY-Breast05 & What Comes Next – Dr. Neil Iyengar & Dr. Komal Jhaveri 4 months ago Cleopatra, DESTINY-Breast09 & What Comes Next – Drs. Bill Gradishar, Tarah Ballinger, & Megan Kruse 4 months ago
Is HER2+ Metastatic Breast Cancer Curable? What Comes Next – Dr. Gregory Vidal & Dr. Nusayba Bagegni 4 months ago
Rethinking First-Line Metastatic HER2+ Therapy with T-DXd – Drs. Mouabbi, O’Shaughnessy & Rimawi 4 months ago
DESTINY-Breast11, DESTINY-Breast05 & What Comes Next – Dr. Neil Iyengar & Dr. Komal Jhaveri 4 months ago
Cleopatra, DESTINY-Breast09 & What Comes Next – Drs. Bill Gradishar, Tarah Ballinger, & Megan Kruse 4 months ago